Venclexta
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(800) 255-5162Website
www.venclexta.comRevenue
$7.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Venclexta
AbbVie and Genentech offer VENCLEXTA® (venetoclax tablets), an oral therapy designed to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML) in specific patient populations. The medication is used in combination with other treatments for newly diagnosed AML patients who are 75 years or older or have other medical conditions that prevent standard chemotherapy. Their services include a nurse support line for treatment-related inquiries, ensuring patients receive guidance and support throughout their treatment journey. The companies prioritize patient safety and provide comprehensive information regarding potential side effects and necessary precautions associated with VENCLEXTA.Explore more
Popular SearchesVenclextaAbbVie IncSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Venclexta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Venclexta has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Venclexta is spiking on competitors!
Click to see if Venclexta had a recent Job posting/layoffs
Product Launch: Get notified when Venclexta launches new products
Congratulate Masked Content for being promoted to Masked Content at Venclexta
Website visits: Recent activity has been detected on your website
Check if Venclexta has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Venclexta recently announced quarterly report
Venclexta, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Venclexta as Masked Content
Find 2 more new buyers
Compare Similar Companies to Venclexta
Compare insights from companies similar to Venclexta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Venclexta
$7.6M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Venclexta is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Venclexta is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Venclexta.
Venclexta Tech Stack
A closer look at the technologies used by Venclexta
See more technologies
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Venclexta
Sign Up For FreeTo access detailed company insights
AbbVie and Genentech offer VENCLEXTA® (venetoclax tablets), an oral therapy designed to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML) in specific patient populations. The medication is used in combination with other treatments for newly diagnosed AML patients who are 75 year... Read More
